TIVC NASDAQ
Tivic Health Systems, Inc.
1W: +4.4%
1M: -40.2%
3M: -68.4%
YTD: -78.2%
1Y: -91.4%
3Y: -99.6%
$0.26
Last traded 2026-07-31 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
32 relationships32
As Filer
counterparties named
0
As Counterparty
mentioned by others
5
Rel. Types
2021-11-18
Earliest Filing
2026-03-13
Latest Filing
partner: 20
investor: 5
supplier: 4
target: 2
acquirer: 1
Counterparties (Filed by TIVC)
32 relationshipsCompanies named in TIVC's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| TPB Merchants Ice LLC | — | partner | Lessor of the Microbial Building facility under an 8-year lease agreement. | 2026-03-13 | View |
| Merchants Ice II, LLC | — | partner | Lessor of the Mammalian Building facility under a 102-month lease agreement. | 2026-03-13 | View |
| Texas Research and Technology Foundation | — | partner | Lessor of office space under a sublease agreement. | 2026-03-13 | View |
| Tumim Stone Capital, LLC | — | investor | Investor in a Common Stock Purchase Agreement and holder of Pre-Funded Warrants. | 2026-02-09 | View |
| Scorpius Holdings, Inc. | SCPX | target | Parent entity whose assets were acquired by the registrant following a default | 2025-12-11 | View |
| Helena Global Investment Opportunities I Ltd. | — | investor | Previous holder of Series B Preferred Stock who assigned rights to 3i, LP | 2025-12-11 | View |
| 3i, LP | TGOPF | investor | Acquired assets via public auction and purchased senior secured convertible notes and preferred stock | 2025-12-11 | View |
| Statera Biopharma, Inc. | — | partner | Licensor of TLR5 agonist programs Entolimod and Entolasta | 2025-07-25 | View |
| Statera Biopharma, Inc. | — | partner | Licensor of TLR5 agonist programs Entolimod and Entolasta | 2025-06-25 | View |
| Avenue Capital | — | partner | Third-party recipient of certain payments and lien holder | 2025-06-25 | View |
| Scorpius BioManufacturing, Inc. | SCPX | supplier | Primary U.S. manufacturer and CDMO partner for GMP validation of Entolimod | 2025-05-14 | View |
| Scorpius Holdings Inc. | SCPX | supplier | Parent company of Scorpius BioManufacturing, Inc. | 2025-05-14 | View |
| Helena Global Investment Opportunities 1 Ltd. | — | investor | Investor purchasing Series B Preferred Stock and Warrants in a securities offering. | 2025-05-02 | View |
| Craft Capital Management LLC | — | partner | Placement agent for the securities offering. | 2025-05-02 | View |
| Mast Hill Fund, L.P. | — | investor | Investor in an equity purchase agreement to purchase up to $25,000,000 of Tivic Health Systems, Inc. common stock. | 2025-03-21 | View |
| Craft Capital Management LLC | — | partner | Placement agent for the equity purchase agreement. | 2025-03-21 | View |
| Statera Biopharma, Inc. | — | partner | Partnered with Tivic Health Systems, Inc. to grant an exclusive worldwide license for Entolimod and Entolasta and sold s | 2025-02-12 | View |
| Maxim Group LLC | MMS | partner | Sales agent for the Company's equity distribution agreement. | 2024-09-13 | View |
| Czarnowski Display Service, Inc. | — | supplier | Counterparty in Sublease Termination Agreement; former sublessor of Tivic Health Systems, Inc. | 2024-05-30 | View |
| The Feinstein Institutes for Medical Research | — | partner | Collaboration and Research Support Agreement for vagus nerve stimulation clinical research program. | 2024-05-22 | View |
| Maxim Group LLC | MMS | partner | Placement agent for the registered public offering | 2024-05-13 | View |
| Equiniti Trust Company, LLC | — | partner | Warrant agent for the Common Warrants issued in the offering | 2024-05-13 | View |
| Maxim Group LLC | MMS | partner | Placement agent for the securities offering | 2023-08-09 | View |
| Equiniti Trust Company | — | partner | Transfer agent for the Company | 2023-08-09 | View |
| Maxim Group LLC | MMS | partner | Placement agent for the securities offering | 2023-07-19 | View |
| Equiniti Trust Company | — | partner | Transfer agent for the Company | 2023-07-19 | View |
| ThinkEquity LLC | — | partner | Representative of the underwriters in the firm commitment public offering of common stock. | 2023-02-13 | View |
| ALOM Technologies Corporation | — | partner | Partner providing fulfillment, assembly, procurement, storage, and logistics services. | 2022-12-01 | View |
| RB Buyer Co, LLC | — | acquirer | Acquired substantially all assets of Reliefband Technologies, LLC for $33.5 million | 2022-10-14 | View |
| Reliefband Technologies, LLC | — | target | Target of asset acquisition by RB Buyer Co, LLC | 2022-10-14 | View |
| Shareholder Representative Services LLC | — | partner | Acted as representative for Reliefband Technologies, LLC and its beneficial owners | 2022-10-14 | View |
| Czarnowski Display Services, Inc. | — | supplier | Sublease agreement for office space | 2021-11-18 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-05-04 | Officer/Director Change; Regulation FD; Exhibits | View | |
| 2026-04-23 | Bylaws Amendment; Exhibits | View | |
| 2026-03-25 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-03-13 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2026-03-11 | Submission of Matters to a Vote of Security Holders; Other Events | View | |
| 2026-03-04 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2026-02-23 | Financial Statements and Exhibits | View | |
| 2026-02-09 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme | Agreement | View |
| 2026-01-20 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-12-11 | Entry into Material Definitive Agreement; Termination of Material Definitive Agreement; Completion o | Agreement Acquisition | View |
| 2025-11-18 | Other Events; Financial Statements and Exhibits | View | |
| 2025-11-14 | Results of Operations and Financial Condition; Costs Associated with Exit or Disposal Activities; Re | View | |
| 2025-11-13 | Other Events; Financial Statements and Exhibits | View | |
| 2025-10-15 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-08-27 | Other Events | View | |
| 2025-08-20 | Other Events; Financial Statements and Exhibits | View | |
| 2025-08-14 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-07-25 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-07-07 | Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit | View | |
| 2025-06-25 | Regulation FD Disclosure; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR